Teri Kreisl

Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

Teri Kreisl, Lyndon Kim, Kraig Moore et al. · Journal of Clinical Oncology · 2008 · 1.6K citations · Full text

Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme

John K. Park, Tiffany R. Hodges, Leopold Arko et al. · Journal of Clinical Oncology · 2010 · 358 citations

177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial

Michael J. Morris, Daniel Castellano, Ken Herrmann et al. · The Lancet · 2024 · 189 citations · Full text

Urology, Oncology, Genitourinary Cancer +8

A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM)

Teri Kreisl, Andrew B. Lassman, Paul S. Mischel et al. · Journal of Neuro-Oncology · 2008 · 171 citations

Neuro-oncology, Glioma, Medicine +11

Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas

Fábio M. Iwamoto, Teri Kreisl, Lyndon Kim et al. · Cancer · 2010 · 118 citations · Full text